RayStation 9B SP1. For radiation treatment planning. — FDA record Z-1403-2022

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Jun 1, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
RayStation 9B SP1. For radiation treatment planning.
Reason
An issue with propagation of treatment course information from RayStation with RayTreat to RayCare has been identified. During some workflows, information may not be propagated to RayCare.
Classification
Class II
Recalling firm
RAYSEARCH LABORATORIES AB
Quantity
1
Agency-reported status
Terminated
Source record identifier
Z-1403-2022

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityUDI-DI: 0735000201029720200310 Build number 9.2.0.483

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Worldwide distribution - US Nationwide distribution in the state of TN and the countries of Belgium and Switzerland.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Jul 27, 2022
Recall initiation date
Jun 1, 2022
Center classification date
Jul 19, 2022
Termination date
Oct 4, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records